BRIEF-CTi biopharma granted 180 day extension by NASDAQ to regain compliance

* CTi Biopharma granted 180 day extension by NASDAQ to regain compliance with minimum bid price rule
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.